Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective
2020 · International Journal of Gynecological Cancer · 177 citations
https://doi.org/10.1136/ijgc-2020-001975
E
Edgar Petru
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
670
Papers
7.8K
Citations
45
h-index
133
i10-index
Edgar Petru is an academic researcher from Medical University of Graz. The author has contributed to research in topics: Ovarian cancer diagnosis and treatment & Endometrial and Cervical Cancer Treatments & PARP inhibition in cancer therapy. The author has an h-index of 45, co-authored 570 publications.
ORCID: 0000-0001-8822-257XPapers by this author
worksThe EndoPredict score predicts response to neoadjuvant chemotherapy and neoendocrine therapy in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients from the ABCSG-34 trial
2020 · European Journal of Cancer · 51 citations
https://doi.org/10.1016/j.ejca.2020.04.020
Pathological Complete Response to Neoadjuvant Trastuzumab Is Dependent on HER2/CEP17 Ratio in HER2-Amplified Early Breast Cancer
2017 · Clinical Cancer Research · 50 citations
https://doi.org/10.1158/1078-0432.ccr-16-2373
Carboplatin–paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer
2011 · British Journal of Cancer · 35 citations
https://doi.org/10.1038/bjc.2011.256
INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line
2023 · British Journal of Cancer · 25 citations
https://doi.org/10.1038/s41416-022-02108-7
Efficacy and safety of everolimus plus exemestane in patients with HR+, HER2− advanced breast cancer progressing on/after prior endocrine therapy in routine clinical practice: Primary results from the non-interventional study, STEPAUT
2020 · The Breast · 20 citations
https://doi.org/10.1016/j.breast.2020.01.035
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat